Investment Rating - The investment rating for AIA Group Limited is maintained at "Buy" with a target price of HKD 100.00 [1][11] Core Insights - AIA Group Limited reported a robust growth in new business value (NBV), which increased by 15% year-on-year, primarily driven by the Hong Kong market. The NBV in Hong Kong saw a strong growth of 28%, while the mainland China market experienced a modest increase of 2% due to assumption adjustments [6][7] - The operating profit after tax (OPAT) per share grew by 12% year-on-year, and the dividend per share (DPS) increased by 10% to HKD 1.93. The company’s solid earnings performance and steady increase in NBV support the "Buy" rating [6][10] Summary by Sections Financial Performance - For the fiscal year 2025, the gross premium income is projected to be USD 21.618 billion, reflecting an 11.93% increase. The total investment income is expected to be USD 17.979 billion, showing a significant increase of 50.62% [5] - The net profit attributable to shareholders is forecasted to be USD 6.234 billion, with a year-on-year decrease of 8.81%. The earnings per share (EPS) is expected to be USD 0.59, while the dividend per share (DPS) is projected to be USD 0.25 [5] Market Analysis - The Hong Kong market is the largest contributor to AIA's NBV growth, with a notable increase in both local residents and mainland visitors. The agent channel's NBV grew by 26%, and the bancassurance channel saw a 41% increase [7] - The mainland China market's NBV growth was limited to 2% due to economic assumption adjustments, but it showed a recovery in the second half of the year with a 14% increase [8] Regional Performance - Southeast Asia markets, including Thailand, Singapore, and Malaysia, showed varied performance with NBV growth of 13%, 14%, and 0% respectively. The overall growth in these markets is expected to be around 5% in 2026 [9] - The new regional markets in mainland China are projected to grow at a compound annual growth rate (CAGR) of 40% from 2025 to 2030, contributing positively to the overall NBV [8] Operational Metrics - The operating return on equity (ROE) for 2025 is expected to be 15.5%, reflecting a year-on-year increase of 0.7 percentage points. The company plans to initiate a new share buyback program worth USD 1.7 billion in 2026 [10][11] - The forecast for EPS has been slightly adjusted to USD 0.72 for 2026, with an expected NBV growth of 16% [11]

Investment Rating - The report maintains a "Buy" rating for Tencent with a target price of HKD 757.33, down from the previous HKD 792 [6][5]. Core Insights - Tencent's 4Q25 performance met expectations, with a revenue growth of 12.7%, slightly above consensus estimates. The company plans to increase AI investments in 2026, with adjusted net profit rising by 17% [1][5]. - The report highlights the improvement in Tencent's agent capabilities, particularly with the launch of AI products like QClaw and WorkBuddy, which are expected to enhance long-term competitiveness in the AI sector [2][3]. - Tencent Cloud achieved an adjusted operating profit of RMB 5 billion in 2025, indicating a turnaround in profitability [3]. Financial Performance - In 4Q25, Tencent's revenue reached RMB 1,944 billion, with a year-over-year growth of 12.7%. The value-added services, advertising, and fintech segments saw growth rates of 14%, 17%, and 8% respectively [12][11]. - The adjusted net profit for 2025 is projected to be RMB 290.6 billion, reflecting a decrease of 2.9% for 2026 and 2.3% for 2027 due to increased AI investment costs [32][5]. - The report forecasts revenue for 2026 to be RMB 845 billion, with a growth rate of 12.4% [10][32]. Game Segment Insights - Domestic game revenue in 4Q25 grew by 15%, with significant contributions from titles like "Valorant" and "Ming Chao" [4][25]. - The upcoming release of "Honor of Kings World" is expected to generate RMB 3-6 billion in its first year, with strong pre-registration numbers [28][29]. AI Investment and Product Development - Tencent plans to double its AI-related investments in 2026, with significant R&D expenditures projected at RMB 180 billion for the year [3][19]. - The company is actively developing its AI product ecosystem, with the OpenClaw series aimed at enhancing user engagement across various applications [13][14]. Advertising and Revenue Growth - Advertising revenue in 4Q25 increased by 17.5%, driven by improvements in eCPM and user engagement on platforms like WeChat and Video Accounts [11][12]. - The report notes that AI-driven advertising has significantly contributed to revenue growth, with a stable increase in exposure and user participation [11].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 44.65 [1]. Core Views - The company has returned to a growth trajectory, achieving a revenue of RMB 918 million in 2025, representing a year-over-year increase of 70.66%, and a net profit of RMB 200 million, reflecting a significant year-over-year increase of 1138.28% [1]. - The growth in revenue and profit is attributed to the recovery in defense construction needs and the successful transition from a component supplier to a system-level supplier in the aerospace sector [1][2]. - The company is expected to continue its growth in the aerospace field, with a strong long-term growth potential in the civil products market [1]. Summary by Sections Financial Performance - In 2025, the company's takeoff and landing system products generated revenue of RMB 614 million, a year-over-year increase of 96.21%, while the inspection and testing business achieved revenue of RMB 252 million, up 20.06% year-over-year [2]. - The gross margin for takeoff and landing system products was 40.97%, down 5.69 percentage points from 2024, primarily due to the increased revenue share from lower-margin landing gear business [2]. Product Development - Multiple landing gear models are in various stages of development, with some entering batch production and others undergoing ground testing [3]. - The civil aviation subsidiary has obtained several NADCAP special process certifications, enhancing the company's capabilities in the civil aviation sector [3]. Cash Flow and Capital Raising - The company has improved its cash flow management, reducing accounts receivable from RMB 1.999 billion at the end of 2023 to RMB 1.482 billion [4]. - The company plans to raise approximately RMB 1.97 billion through a private placement to enhance its core competitiveness, focusing on expanding landing gear production capacity and civil aviation product industrialization [4]. Profit Forecast and Valuation - The forecasted net profit for 2026-2028 is RMB 269 million, RMB 368 million, and RMB 469 million, respectively, with a compound annual growth rate of 32.87% [5]. - The target price has been adjusted to RMB 44.65, based on a price-to-earnings ratio of 55 times for 2026 [5].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 77.60 [6]. Core Views - The company reported a revenue of HKD 7.71 billion for 2025, a decrease of 16.1% year-on-year, primarily due to a reduction in interest income from loans to associated companies. However, the net profit attributable to shareholders was HKD 6.236 billion, reflecting a year-on-year increase of 1.9%, which is in line with expectations [1][4]. - The company is expected to benefit from an increase in return rates for several regulated assets entering new regulatory periods in 2026, which supports future earnings growth. The sale of UK Power Networks (UKPN) is anticipated to significantly enhance cash reserves and improve the company's capacity for global expansion and acquisitions [3][4]. - The Australian business contributed a profit of HKD 1.461 billion in 2025, up 4% year-on-year, driven by regulatory changes allowing for a return rate increase. The Hong Kong business remained stable, contributing HKD 1.051 billion, while the UK business's profit contribution was flat due to high base effects from the previous year [2][3]. Summary by Sections Financial Performance - The company achieved a revenue of HKD 7.71 billion in 2025, down 16.1% year-on-year. The net profit attributable to shareholders was HKD 6.236 billion, up 1.9% year-on-year. The dividend per share (DPS) for 2025 is HKD 2.82, maintaining a dividend payout ratio of 96% [1][4]. - The projected net profits for 2026-2028 are HKD 7.159 billion, HKD 7.264 billion, and HKD 7.561 billion, respectively, indicating a growth trajectory [4][9]. Regulatory Changes and Future Outlook - Several regulated assets are entering new regulatory periods in 2026, which is expected to lead to increased return rates. For instance, Northumbrian Water's return rate is set to increase by 0.83 percentage points to 4.03% [3]. - The company anticipates that the UKPN equity sale will be completed by the end of June 2026, potentially generating a profit contribution of approximately HKD 3 billion [2][4]. Valuation Metrics - The report estimates the company's price-to-book (PB) ratio at 1.80x for 2026, with a target price of HKD 77.60, reflecting a positive outlook based on historical averages and expected performance improvements [4][9].

Investment Rating - The industry investment rating is "Overweight" [7] Core Viewpoints - The electronic gas market is expected to grow significantly, with a projected global market size of $6.8 billion in 2026, reflecting an 8% year-on-year increase [1] - The demand for electronic gases is driven by advancements in chip manufacturing technologies, including new storage technologies and advanced packaging [3] - The domestic market share of listed companies in China's electronic gas sector is currently 40%, with expectations for increased localization due to rising self-sufficiency requirements and anti-dumping measures [5] Summary by Sections Global Market Outlook - The global electronic gas market is projected to reach $6.8 billion in 2026, with a year-on-year growth of 8% [1] - The market for electronic specialty gases is expected to grow from $4.64 billion in 2025 to $5.04 billion in 2026, while electronic bulk gases are expected to grow from $1.67 billion to $1.78 billion in the same period [3] Domestic Market Dynamics - China's electronic gas market is expected to grow to 22.2 billion yuan in 2026, representing a 7% year-on-year increase [4] - The expansion of domestic storage and wafer factories is anticipated to support the demand for electronic gases [4] Supply Chain and Localization - The localization rate of electronic specialty gases in China is expected to increase from 9% in 2018 to 25% by 2025 [5] - The ongoing geopolitical tensions in the Middle East are affecting helium supply, leading to increased prices and potential benefits for domestic helium gas companies [2][5] Technological Advancements - The shift towards advanced semiconductor processes is expected to increase the consumption of various electronic gases, enhancing their value in manufacturing [4] - The capital expenditure of storage chip companies is projected to accelerate in 2026, further driving the demand for electronic gases [3]

Investment Rating - The report maintains a "Buy" rating for the company [5][4]. Core Insights - The company reported a revenue of 4.616 billion RMB for 2025, representing a year-over-year increase of 12.1%. Adjusted net profit reached 791.99 million RMB, up 50.9% year-over-year, benefiting from optimized course structures and cost management [1][2]. - The company continues to uphold a high dividend policy, declaring an annual dividend of 665 million HKD for 2025, which accounts for approximately 84% of the adjusted net profit. The company commits to a payout ratio of no less than 60% over the next three years, highlighting stable shareholder returns [1][2]. - The company has entered a high-quality development phase characterized by steady revenue growth and profit elasticity, supported by enhanced educational levels and new program layouts [1][2]. Summary by Sections Financial Performance - In 2025, the company achieved a total enrollment of 151,341 new training participants, a 5.5% increase year-over-year. The average training fee per participant rose by 5.7% to approximately 30,000 RMB, driving double-digit revenue growth [2]. - The growth was primarily driven by a shift towards higher-value courses, with new enrollments in high-priced 1-2 year programs increasing by 66.2%. The beauty industry segment saw a revenue increase of 71.7%, with a gross margin of 63%, becoming a significant profit driver [2]. - Overall gross margin improved by 3.9 percentage points to 55.3%, with administrative and sales expense ratios optimized by about 1 percentage point, leading to an adjusted net profit margin increase of approximately 4.4 percentage points [2]. Strategic Developments - The company has elevated its educational offerings, with the Guizhou New Oriental Culinary Advanced Technician School upgraded to a technician college, adding to its existing three technician colleges, which is expected to enhance student recruitment [3]. - The company has strategically established vocational education industrial parks in multiple provinces, including Sichuan and Shandong, to improve operational efficiency through centralized training and resource allocation [3]. - New program initiatives in pet care and caregiving services are underway, with the pet care program expected to start enrolling students within the year, representing a new growth avenue [3]. Valuation and Forecast - The adjusted net profit forecasts for 2026-2028 have been slightly revised to 1.002 billion RMB, 1.200 billion RMB, and 1.451 billion RMB, reflecting a decrease of 3% to 8% from previous estimates. The target price is set at 9.36 HKD, based on a comparable company PE of 18.43x for 2026 [4][5].

Investment Rating - The report maintains a "Buy" rating for Tencent with a target price of 757.33 HKD, down from the previous 792 HKD, corresponding to a 20.8x PE valuation for 2026 [6][5]. Core Insights - Tencent's 4Q25 performance met expectations, with a revenue growth of 12.7%, slightly above consensus estimates. The company plans to increase AI investments in 2026, with a focus on enhancing its agent capabilities [1][2]. - The report highlights Tencent's strategic shift towards AI products, with the launch of OpenClaw and related applications, indicating a competitive edge in the AI landscape [2][3]. - Tencent Cloud achieved an adjusted operating profit of 5 billion RMB in 2025, marking a turnaround, while the company anticipates a doubling of AI-related investments in 2026 [3][5]. Financial Performance - In 4Q25, Tencent's domestic game revenue grew by 15%, with significant contributions from new titles. The report suggests monitoring the revenue from upcoming games in March and April [4][28]. - The adjusted net profit for Tencent is projected to be 290.6 billion RMB for 2026, reflecting a slight decrease due to increased AI spending [32][5]. - The report forecasts Tencent's revenue for 2026 to be 845.1 billion RMB, with a growth rate of 12.4% [10][32]. AI Product Development - Tencent is intensifying its AI product development, with significant investments in the Claw product line, which includes QClaw and WorkBuddy, aimed at enhancing user engagement and operational efficiency [2][13]. - The company is focusing on integrating AI into its existing platforms, with plans for deeper integration of AI capabilities into WeChat [3][13]. - The report notes that Tencent's AI products are expected to evolve from general models to more specialized applications across various sectors, enhancing long-term competitiveness [2][3]. Game Revenue and Projections - The report emphasizes the strong performance of Tencent's gaming segment, with expectations for new game releases to drive revenue growth in the upcoming quarters [4][28]. - The anticipated launch of "Honor of Kings World" in April 2026 is projected to generate 3-6 billion RMB in its first year, leveraging the existing user base of the original game [28][29]. - Overall, Tencent's gaming revenue is expected to continue its upward trajectory, supported by new titles and seasonal events [25][28].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 44.65 [1]. Core Views - The company has returned to a growth trajectory, achieving a revenue of RMB 918 million in 2025, representing a year-over-year increase of 70.66%, and a net profit of RMB 200 million, reflecting a significant year-over-year increase of 1138.28% [1]. - The growth in revenue and profit is attributed to the recovery in defense construction needs and the successful transition from a component supplier to a system-level supplier in the aerospace sector [1][2]. - The company is expected to continue its growth in the aerospace field, with a strong outlook for its civil products business [1]. Summary by Sections Financial Performance - In 2025, the company generated revenue of RMB 918 million, with a year-over-year growth of 70.66%. The net profit reached RMB 200 million, marking a year-over-year increase of 1138.28% [1]. - The fourth quarter of 2025 saw revenue of RMB 268 million, a year-over-year increase of 389.21% and a quarter-over-quarter increase of 40.46% [1]. Business Segments - The takeoff and landing system products generated revenue of RMB 614 million in 2025, up 96.21% year-over-year, while the inspection and testing business achieved revenue of RMB 252 million, a 20.06% increase year-over-year [2]. - The takeoff and landing system products had a gross margin of 40.97%, which decreased by 5.69 percentage points from the previous year due to the higher revenue contribution from lower-margin landing gear business [2]. Development and Innovation - Multiple landing gear models are in various stages of development, with some entering batch production and others undergoing flight tests [3]. - The company’s subsidiary has obtained several NADCAP special process certifications, enhancing its capabilities in the civil aviation sector [3]. Cash Flow and Financial Health - The company improved its cash flow management, reducing accounts receivable from RMB 1.999 billion at the end of 2023 to RMB 1.482 billion [4]. - The operating cash flow for 2025 was RMB 378 million, significantly up from RMB 185 million in 2024 [4]. Profit Forecast and Valuation - The forecasted net profit for 2026-2028 is RMB 269 million, RMB 368 million, and RMB 469 million, respectively, with a compound annual growth rate of 32.87% [5]. - The target price has been adjusted to RMB 44.65, based on a price-to-earnings ratio of 55 times for 2026 [5].

Investment Rating - The report maintains an "Overweight" rating for the biopharmaceutical and chemical pharmaceutical sectors [6]. Core Insights - The Chinese innovative drug sector is at the beginning of a long cycle, with continuous global output of high-quality assets from Chinese companies. The potential of these assets is not fully reflected in A/H share pricing, leading to a recommendation for the innovative drug sector [1]. - The number and value of business development (BD) deals in the Chinese innovative drug industry have reached record highs in 2023, with 45 BD deals completed (+73% year-on-year) and a total disclosed amount of $57.5 billion (+135% year-on-year) [2]. - The report highlights a significant valuation gap between A/H shares and US stocks for similar innovative drug assets, indicating that A/H shares are systematically undervalued [4]. Summary by Sections Business Development Trends - The report notes that the Chinese innovative drug sector has achieved a global market share of approximately 20% in the number of BD projects and around 75% in the disclosed amount [2]. - There is a high predictability of continued growth in BD activities, driven by increasing interest from multinational corporations (MNCs) and private equity (PE) firms in Chinese assets [2]. Cash Flow Contributions - The report emphasizes that platform companies in China are expected to generate sustainable cash flows through ongoing BD activities, which have not been adequately valued in the market [3]. - It is projected that significant BD deals (with upfront payments exceeding $500 million) will contribute to continuous cash flow growth for companies like Heng Rui Medicine, Shiyao Group, and others [3]. Valuation Comparisons - The report compares the valuations of similar assets in A/H shares and US markets, revealing that Chinese innovative drug companies are undervalued relative to their US counterparts [4][19]. - Specific case studies illustrate the valuation discrepancies, such as between MSD and Kelun Biotech, and Insmed and Haizhi Pharmaceutical, highlighting the potential for significant upside in A/H share valuations [19][22]. Investment Recommendations - The report recommends focusing on large pharmaceutical and biopharmaceutical companies with sustained BD capabilities, including Heng Rui Medicine, Shiyao Group, and others [5]. - Companies that have completed large BD deals are expected to benefit from ongoing milestone cash flows, with specific recommendations for companies like Kelun Biotech and Rongchang Biopharmaceutical [5]. Target Prices and Market Outlook - Target prices for recommended stocks are provided, with specific price targets for companies such as Shiyao Group at HKD 19.25 and Heng Rui Medicine at HKD 98.43, indicating a bullish outlook for these stocks [26].

Investment Rating - The report maintains an "Overweight" rating for the diversified financial sector [2] Core Insights - The Middle Eastern capital markets have a total market size comparable to Hong Kong, with a combined market value of approximately $4.9 trillion in 2025, while Hong Kong's market value reached $5.6 trillion [11][47] - The market structure in the Middle East is fragmented, with each country typically having its own independent stock exchange, leading to a lack of a unified capital market center [7][20] - Saudi Arabia dominates the market with an average market capitalization of about $2.51 trillion in 2025, significantly higher than other markets in the region [8][26] - The trading activity in the Middle East is characterized by low liquidity, with a total trading volume of approximately $1.9 trillion in 2025, compared to Hong Kong's $7.9 trillion [9][50] Market Structure - The market capitalization distribution shows a clear tiered structure, with Saudi Arabia in the first tier, followed by the UAE's Abu Dhabi and Dubai exchanges in the second tier, and Turkey's Istanbul exchange and Israel's TASE in the third tier [8][26] - The Saudi market is heavily influenced by the state-owned oil giant Saudi Aramco, which accounts for over 60% of the total market capitalization [34] Trading Characteristics - The overall liquidity in the Middle Eastern markets is low, with significant internal differences; for instance, Istanbul's exchange has a turnover rate of 276%, while Saudi Arabia's is only 13.9% [9][51] - The investor structure in Saudi Arabia is predominantly institutional, with over 95% of shares held by institutional investors, leading to lower trading activity [51] Geopolitical Context - The ongoing geopolitical tensions in the Middle East have increased uncertainty in the capital markets, prompting some funds to reduce risk exposure and shift towards more liquid markets like the US or Hong Kong [12][13] - The Hong Kong Stock Exchange has included exchanges from Abu Dhabi, Dubai, and Saudi Arabia in its list of recognized overseas exchanges, which may enhance cross-border listing opportunities for Middle Eastern companies [16] Valuation Insights - Hong Kong's stock market is currently seen as relatively undervalued, with a PE ratio of 15.6x as of February 2026, making it attractive for Middle Eastern funds seeking to invest in Asia [17]